- Home
- AMPH
as 12-20-2024 3:30pm EST
Amphastar Pharmaceuticals Inc is a biopharmaceutical company that focuses on developing, manufacturing, marketing, and selling technically challenging generic and proprietary injectable, inhalation, and intranasal products. Additionally, the company sells insulin API products. The company's finished products are used in hospital or urgent care clinical settings and are contracted and distributed through group purchasing organizations and drug wholesalers. The company has two reportable segments finished pharmaceutical products and API products. Geographically the business presence of the firm is seen in the United States, China and France of which the U.S. accounts for the majority of the revenue.
| Founded: | 1996 | Country: | United States |
| Employees: | N/A | City: | RANCHO CUCAMONGA |
| Market Cap: | 2.5B | IPO Year: | 2014 |
| Target Price: | $60.33 | AVG Volume (30 days): | 607.1K |
| Analyst Decision: | Buy | Number of Analysts: | 4 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | 3.01 | EPS Growth: | 17.38 |
| 52 Week Low/High: | $36.56 - $65.92 | Next Earning Date: | 11-06-2024 |
| Revenue: | $723,549,000 | Revenue Growth: | 20.33% |
| Revenue Growth (this year): | 16.86% | Revenue Growth (next year): | 10.07% |
Stock Insider Trading Activity of Amphastar Pharmaceuticals Inc. (AMPH)
| Name | Ticker | Relationship | Date | Transaction | AVG Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| Zhou Rong | AMPH | SENIOR EVP, PRODUCTION CENTER | Dec 12 '24 | Sell | $44.83 | 15,000 | $672,815.00 | 118,469 | |
| PRINS RICHARD K | AMPH | Director | Dec 9 '24 | Sell | $43.77 | 10,000 | $437,702.00 | 30,471 | |
| Zhou Rong | AMPH | SENIOR EVP, PRODUCTION CENTER | Nov 12 '24 | Sell | $48.88 | 6,893 | $336,929.84 | 118,469 | |
| PRINS RICHARD K | AMPH | Director | Nov 12 '24 | Sell | $48.80 | 5,000 | $243,985.50 | 30,471 | |
| Liawatidewi Yakob | AMPH | EVP CORP ADMIN CENTER | Nov 6 '24 | Sell | $52.05 | 5,214 | $271,388.70 | 74,938 | |
| PETERS WILLIAM J | AMPH | CFO, EVP & TREASURER | Nov 6 '24 | Sell | $52.05 | 7,426 | $386,523.30 | 94,103 |
Latest Amphastar Pharmaceuticals Inc. News
AMPH Breaking Stock News: Dive into AMPH Ticker-Specific Updates for Smart Investing
Argus Research
4 days ago
AMPH: Lowering target price to $43.00
MT Newswires
6 days ago
Amphastar Pharmaceuticals Insider Sold Shares Worth $672,815, According to a Recent SEC Filing
Argus Research
11 days ago
AMPH: Lowering target price to $46.00
Simply Wall St.
17 days ago
Should You Be Adding Amphastar Pharmaceuticals (NASDAQ:AMPH) To Your Watchlist Today?
Zacks
18 days ago
Implied Volatility Surging for Amphastar Pharmceuticals (AMPH) Stock Options
Argus Research
18 days ago
AMPH: Raising target price to $47.00
Insider Monkey
22 days ago
Why Amphastar Pharmaceuticals (AMPH) Is One of the Most Profitable Pharmaceutical Stocks Right Now?
Argus Research
25 days ago
AMPH: What does Argus have to say about AMPH?
Compare AMPH vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "AMPH Amphastar Pharmaceuticals Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.